Fernwood Investment Management’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-169
| Closed | -$3.17K | – | 602 |
|
|
2024
Q1 | $3.17K | Buy |
+169
| New | +$3.17K | ﹤0.01% | 657 |
|
|
2018
Q4 | – | Sell |
-4,837
| Closed | -$683K | – | 168 |
|
|
2018
Q3 | $683K | Hold |
4,837
| – | – | 0.36% | 74 |
|
|
2018
Q2 | $757K | Hold |
4,837
| – | – | 0.41% | 69 |
|
|
2018
Q1 | $779K | Sell |
4,837
-3,629
| -43% | -$584K | 0.43% | 62 |
|
|
2017
Q4 | $1.39M | Buy |
8,466
+66
| +0.8% | +$10.9K | 0.75% | 43 |
|
|
2017
Q3 | $523K | Buy |
8,400
+258
| +3% | +$16.1K | 0.33% | 78 |
|
|
2017
Q2 | $648K | Hold |
8,142
| – | – | 0.47% | 60 |
|
|
2017
Q1 | $579K | Buy |
8,142
+2,907
| +56% | +$207K | 0.46% | 58 |
|
|
2016
Q4 | $267K | Hold |
5,235
| – | – | 0.26% | 102 |
|
|
2016
Q3 | $241K | Buy |
+5,235
| New | +$241K | 0.22% | 101 |
|